Novartis AG (NYSE:NVS)

88.85
Delayed Data
As of 4:00pm ET
 -0.69 / -0.77%
Today’s Change
79.34
Today|||52-Week Range
98.52
+1.58%
Year-to-Date
3 Under-the-Radar COVID Stocks
7:55am / MotleyFool.com - Paid Partner Content
3 Top Biotech Stocks to Buy Right Now
Jan 15 / MotleyFool.com - Paid Partner Content
Ionis' (IONS) Partner to Begin New Huntington's Disease Study
Jan 18 / Zacks.com - Paid Partner Content
Where Will Biogen Be in 5 Years?
Jan 15 / MotleyFool.com - Paid Partner Content
Dodge & Cox Global Stock Fund's 4th-Quarter Commentary
Jan 17 / GuruFocus News - Paid Partner Content
Is electroCore a Good Stock to Add to Your Healthcare Portfolio?
Jan 14 / StockNews.com - Paid Partner Content
Dodge & Cox Stock Fund's 4th-Quarter Commentary
Jan 17 / GuruFocus News - Paid Partner Content
Molecular (MOLN), Novartis Post Positive Data From COVID-19 Drug
Jan 11 / Zacks.com - Paid Partner Content
Glaxo (GSK) Rejects Unilever's $68B Bid for Consumer Business
Jan 17 / Zacks.com - Paid Partner Content
Why Molecular Partners Stock Crushed the Market Today
Jan 10 / MotleyFool.com - Paid Partner Content
GlaxoSmithKline - Catalysts Ahead
Jan 17 / GuruFocus News - Paid Partner Content
Novartis (NVS) Partners With Alnylam for Liver-Targeted Therapies
Jan 07 / Zacks.com - Paid Partner Content